{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T16:08:04Z","timestamp":1790870884700,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.jiac.2020.10.002","type":"journal-article","created":{"date-parts":[[2020,10,23]],"date-time":"2020-10-23T09:15:10Z","timestamp":1603444510000},"page":"424-433","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Meta-analysis of fluoroquinolones versus macrolides for treatment of legionella pneumonia"],"prefix":"10.1016","volume":"27","author":[{"given":"Hideo","family":"Kato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mao","family":"Hagihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhiro","family":"Asai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"Shibata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Koizumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuka","family":"Yamagishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshige","family":"Mikamo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2020.10.002_bib1","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1086\/425921","article-title":"Legionnaires disease and the updated IDSA guidelines for community-acquired pneumonia","volume":"39","author":"Yu","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2020.10.002_bib2","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/BF03256652","article-title":"Legionnaires' disease: update on epidemiology and management options","volume":"2","author":"Sabria","year":"2003","journal-title":"Am J Respir Med"},{"key":"10.1016\/j.jiac.2020.10.002_bib3","first-page":"1384","article-title":"Legionnaires' disease: clinical, epidemiological, and public health perspectives","author":"Breiman","year":"1998","journal-title":"Semin Respir Infect"},{"key":"10.1016\/j.jiac.2020.10.002_bib4","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1016\/j.ijid.2010.09.007","article-title":"Progress in the surveillance and control of Legionella infection in France","volume":"15","author":"Campese","year":"2011","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.jiac.2020.10.002_bib5","first-page":"1007","article-title":"Legionella pneumophila. A cause of severe community-acquired pneumonia","volume":"100","author":"Falco","year":"1991","journal-title":"Chest"},{"key":"10.1016\/j.jiac.2020.10.002_bib6","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1164\/rccm.201908-1581ST","article-title":"Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America","volume":"200","author":"Metlay","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jiac.2020.10.002_bib7","doi-asserted-by":"crossref","DOI":"10.1136\/thx.2009.121434","article-title":"BTS guidelines for the management of community acquired pneumonia in adults: update 2009","volume":"64","author":"Lim","year":"2009","journal-title":"Thorax"},{"key":"10.1016\/j.jiac.2020.10.002_bib8","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1093\/jac\/dku159","article-title":"Quinolones versus macrolides in the treatment of legionellosis: a systematic review and meta-analysis","volume":"69","author":"Burdet","year":"2014","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.jiac.2020.10.002_bib9","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1093\/cid\/ciw490","article-title":"SOLITAIRE-IV: a randomized, double-blind, multicenter study comparing the efficacy and safety of intravenous-to-oral solithromycin to intravenous-to-oral moxifloxacin for treatment of community-acquired bacterial pneumonia","volume":"63","author":"File","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2020.10.002_bib10","doi-asserted-by":"crossref","first-page":"b2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews nd meta-analyses: the PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.jiac.2020.10.002_bib11","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/j.jse.2013.01.017","article-title":"An assessment of the quality of rotator cuff randomized controlled trials: utilizing the Jadad score and CONSORT criteria","volume":"22","author":"McCormick","year":"2013","journal-title":"J\u00a0Shoulder Elbow Surg"},{"key":"10.1016\/j.jiac.2020.10.002_bib12","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane collaboration's tool for assessing risk of bias in randomized trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.jiac.2020.10.002_bib13","series-title":"The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses","author":"Wells","year":"2000"},{"key":"10.1016\/j.jiac.2020.10.002_bib14","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1183\/09031936.95.08121999","article-title":"Treatment of community-acquired pneumonia: a randomized comparison of sparfloxacin, amoxycillin-clavulanic acid and erythromycin","volume":"8","author":"Lode","year":"1995","journal-title":"Eur Rep J"},{"key":"10.1016\/j.jiac.2020.10.002_bib15","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0149-2918(02)85136-0","article-title":"A\u00a0prospective, double-blind, multicenter study comparing clarithromycin extended-release with trovafloxacin in patients with community-acquired pneumonia","volume":"24","author":"Sokol","year":"2002","journal-title":"Clin Therapeut"},{"key":"10.1016\/j.jiac.2020.10.002_bib16","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1086\/378406","volume":"38","author":"Fogarty","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2020.10.002_bib17","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S1473-3099(16)00017-7","article-title":"Efficacy and safety of oral solithromycin versus oral moxifloxacin for treatment of community-acquired bacterial pneumonia: a global, double-blind, multicenter, randomized, active-controlled, non-inferiority trial (SOLITRIRE-ORAL)","volume":"16","author":"Barrera","year":"2016","journal-title":"Lanset Infect Dis"},{"issue":"Supple B","key":"10.1016\/j.jiac.2020.10.002_bib18","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/jac\/26.suppl_B.129","article-title":"Comparison of the activity of three antibiotic regimens in severe Legionnaires' disease","volume":"26","author":"Dournon","year":"1990","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.jiac.2020.10.002_bib19","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1007\/s00134-002-1304-8","article-title":"Severe pneumonia due to Legionella pneumophilia: prognostic factors, impact of delayed appropriate antimicrobial therapy","volume":"28","author":"Gacouin","year":"2002","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jiac.2020.10.002_bib20","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1086\/428059","article-title":"Clinical outcomes for hospitalized patients with Legionella pneumonia in the antigenuria era: influence of levofloxacin therapy","volume":"40","author":"Mykietiuk","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2020.10.002_bib21","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1378\/chest.128.3.1401","article-title":"Fluoroquinolones vs macrolides in the treatment of Legionnaires disease","volume":"128","author":"Sabria","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.jiac.2020.10.002_bib22","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1086\/428049","article-title":"Antimicrobial chemotherapy for Legionnaires disease: levofloxacin versus macrolides","volume":"40","author":"Blazquez Garrido","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2020.10.002_bib23","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ijantimicag.2004.07.013","article-title":"Levofloxacin versus ceftriaxone plus clarithromycin in the treatment of adults with community-acquired pneumonia requiring hospitalization","volume":"25","author":"Querol-Ribelles","year":"2005","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jiac.2020.10.002_bib24","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2169\/internalmedicine.46.6006","article-title":"Intravenous ciprofloxacin versus erythromycin in the treatment of Legionella pneumonia","volume":"46","author":"Haranaga","year":"2007","journal-title":"Intern Med"},{"key":"10.1016\/j.jiac.2020.10.002_bib25","first-page":"222","article-title":"The clinical efficacy of fluoroquinolone and macrolide combination therapy compared with single-agent therapy against community-acquired pneumonia caused by Legionella pneumophila","volume":"59","author":"Nakamura","year":"2009","journal-title":"J\u00a0Infect"},{"key":"10.1016\/j.jiac.2020.10.002_bib26","first-page":"495","article-title":"Macrolides versus quinolones in Legionella pneumonia: results from the community-acquired pneumonia organization international study","volume":"14","author":"Griffin","year":"2010","journal-title":"Int J Tubercul Lung Dis"},{"key":"10.1016\/j.jiac.2020.10.002_bib27","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1093\/jac\/dkx007","article-title":"Antimicrobial strategy for severe community-acquired legionnaires' disease: a multicenter retrospective observation study","volume":"72","author":"Cecchini","year":"2017","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.jiac.2020.10.002_bib28","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.cmi.2017.02.030","article-title":"Levofloxacin versus azithromycin for treating legionella pneumonia: a propensity score analysis","volume":"23","author":"Garcia-Vidal","year":"2017","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jiac.2020.10.002_bib29","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/s15010-019-01340-3","article-title":"Macrolides or fluoroquinolones as enteral antibiotic therapy for non-ICU legionellosis","volume":"47","author":"Scussel","year":"2019","journal-title":"Infection"},{"key":"10.1016\/j.jiac.2020.10.002_bib30","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1086\/342903","article-title":"Trends in legionnaires disease, 1980-1998: declining mortality and new patterns of diagnosis","volume":"35","author":"Benin","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2020.10.002_bib31","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1128\/AAC.01639-13","article-title":"Antimicrobial activity of solithromycin against clinical isolates of Legionella pneumophila","volume":"58","author":"Mallegol","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2020.10.002_bib32","doi-asserted-by":"crossref","first-page":"e13333","DOI":"10.1111\/ijcp.13333","article-title":"Solithromycin monotherapy for treatment of community-acquired bacterial pneumonia: a meta-analysis of randomized controlled trials","volume":"73","author":"Wen","year":"2019","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.jiac.2020.10.002_bib33","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1128\/AAC.00197-13","article-title":"Randomized, double-blind, multicenter phase 2 study comparing the efficacy and safety of oral solithromcyin (CEM-101) to those of oral levofloxacin in the treatment of patients with community-acquired bacterial pneumonia","volume":"57","author":"Oldach","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2020.10.002_bib34","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/jac\/17.suppl_B.41","article-title":"Efficacy of pefloxacin in comparison with erythromycin in the treatment of experimental Guinea pig legionellosis","volume":"17","author":"Dournon","year":"1986","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.jiac.2020.10.002_bib35","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1128\/AAC.34.11.2122","article-title":"In\u00a0vitro activity of sparfloxacin CI-978; AT-4140. For clinical Legionella isolates, pharmacokinetics in Guinea pigs, and use to treat Guinea pigs with L. pneumophila pneumonia","volume":"34","author":"Edelstein","year":"1990","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2020.10.002_bib36","first-page":"409","article-title":"Activity of macrolides and fluoroquinolones against intracellular Legionella pneumophila","volume":"34","author":"Yu","year":"2011","journal-title":"Zhonghua Jiehe He Huxi Zazhi"},{"key":"10.1016\/j.jiac.2020.10.002_bib37","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0934-8840(89)80027-1","article-title":"Pathogenesis and chemotherapy of experimental Legionella pneumophila infection in the chick embryo","volume":"271","author":"Tzianabos","year":"1989","journal-title":"Zentralbl Bakteriol"},{"key":"10.1016\/j.jiac.2020.10.002_bib38","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1093\/jac\/dky253","article-title":"Antibiotic susceptibility of Legionella pneumophila strains isolated in England and Wales 2007-17","volume":"73","author":"Wilson","year":"2018","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.jiac.2020.10.002_bib39","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00768-19","article-title":"Antibiotic resistance and azithromycin resistance mechanism of legionella pneumophila serogroup 1 in China","volume":"63","author":"Jia","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2020.10.002_bib40","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.jiac.2018.01.018","article-title":"In\u00a0vitro activity of various antibiotics against clinical strains of legionella species isolated in Japan","volume":"24","author":"Miyashita","year":"2018","journal-title":"J\u00a0Infect Chemother"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X20303615?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X20303615?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T19:01:31Z","timestamp":1761159691000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X20303615"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S1341321X20303615"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2020.10.002","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Meta-analysis of fluoroquinolones versus macrolides for treatment of legionella pneumonia","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2020.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}